Skip to content
10-Q

Quarterly Report

VYCOR MEDICAL, INC. VYCO

0001493152-24-045025

← back to feed
Filed
Nov 13, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 13, 2024 33.37M sh
Cash And Equivalents Q3 2024 · Sep 30, 2024 $157.63K
Cash And Equivalents Q3 2024 · Dec 31, 2023 $57.29K
Current Liabilities Q3 2024 · Sep 30, 2024 $4.55M
Current Liabilities Q3 2024 · Dec 31, 2023 $4.07M
Total Liabilities Q3 2024 · Sep 30, 2024 $4.76M
Total Liabilities Q3 2024 · Dec 31, 2023 $4.32M
Current Assets Q3 2024 · Sep 30, 2024 $743.43K
Current Assets Q3 2024 · Dec 31, 2023 $584.09K
Total Assets Q3 2024 · Sep 30, 2024 $1.07M
Total Assets Q3 2024 · Dec 31, 2023 $992.3K
Capex Q3 2024 · Sep 30, 2023 $3.48K
Operating Cash Flow Q3 2024 · Sep 30, 2023 $23.92K
Stockholders Equity Q3 2024 · Sep 30, 2023 −$3.23M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$3.02M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$2.94M
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.01
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.01
Eps Basic Q3 2024 · Sep 30, 2023 −$0.01
Eps Basic Q3 2024 · Sep 30, 2023 −$0.01
Sga Expense Q3 2024 · Sep 30, 2023 $280.11K
Sga Expense Q3 2024 · Sep 30, 2023 $881.74K
Rd Expense Q3 2024 · Sep 30, 2023 $7.25K
Rd Expense Q3 2024 · Sep 30, 2023 $20.31K
Net Income Q3 2024 · Sep 30, 2023 −$51.9K
Net Income Q3 2024 · Sep 30, 2023 $23.36K
Operating Income Q3 2024 · Sep 30, 2023 −$25.48K
Operating Income Q3 2024 · Sep 30, 2023 $104.25K
Gross Profit Q3 2024 · Sep 30, 2023 $276.26K
Gross Profit Q3 2024 · Sep 30, 2023 $1.05M
Cost Of Revenue Q3 2024 · Sep 30, 2023 $32.33K
Cost Of Revenue Q3 2024 · Sep 30, 2023 $102.93K
Revenue Q3 2024 · Sep 30, 2023 $308.59K
Revenue Q3 2024 · Sep 30, 2023 $1.15M